Ireland
Borregaard ASA (FRA:BO4) Q2 2024 Earnings Call Transcript Highlights: Mixed Results with Record BioSolutions Performance
EBITDA: NOK510 million, down from NOK537 million a year ago.EBITDA Margin: 26.2%, about 2 percentage points below last year.Earnings Per Share (EPS): NOK2.45,
![Borregaard ASA (FRA:BO4) Q2 2024 Earnings Call Transcript Highlights: Mixed Results with Record BioSolutions Performance](https://europe.easybranches.com/uploads/news/2024/07/6591440.jpg)
Related
Share this page
Guest Posts by Easy Branches